Genetic testing: At 13 years of age, mutation analysis revealed a homozygous, pathogenic nonsense mutation c.2368C> T (p.Gln790Ter) in MAN2B1; thus, confirming the diagnosis of AM. This evidence concerns the gene MAN2B1 and acute myeloblastic leukemia with maturation.